Search for: "Rantanen" Results 161 - 180 of 395
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Feb 2016, 7:44 am by Jason Rantanen
By Jason Rantanen Saurabh Vishnubhakat (Texas A&M), Arti Rai (Duke) and Jay Kesan (Illinois) recently released a draft of their empirical study of Patent Trial and Appeal Board proceedings, Strategic Decision Making in Dual PTAB and District Court Proceedings. [read post]
11 Jun 2014, 1:01 pm by Jason Rantanen
By Jason Rantanen I’m currently spending much of my time attempting to untangle the mess that is the law around Section 284 enhanced damages (i.e.: willful infringement) and Section 285 attorney fee awards (i.e.: exceptional case determinations). [read post]
27 Oct 2011, 10:29 am by Rantanen
By Jason Rantanen As I commented yesterday, the Federal Circuit's statistics page no longer provides information about the disposal of patent infringement appeals by merits panels. [read post]
25 Jun 2014, 2:13 pm by Jason Rantanen
By Jason Rantanen Today, the patent office issued new instructions (download: PTO Alice Instructions) for patent examiners to follow when examining claims for compliance with Section 101. [read post]
2 Jun 2015, 11:08 am by Jason Rantanen
By Jason Rantanen Last month, Pricewaterhouse Cooper released its annual patent litigation study. [read post]
16 Sep 2012, 11:58 am by Lisa Larrimore Ouellette
, by Jason Rantanen & Lee Petherbridge (summarized by Rantanen on Patently-O)Hollywood Deals: Soft Contracts for Hard Markets, by Jonathan BarnettFeaturing People in Ads, by Eric Goldman & Rebecca TushnetSolving the Patent Settlement Puzzle, by Einer Elhauge & Alex KruegerWhile all of these articles look interesting, as I've noted before, I think there is only a weak correlation between SSRN downloads and quality of scholarship; e.g., right now I am the #3 law… [read post]
1 May 2011, 11:54 am by Rantanen
By Jason Rantanen Rembrandt Data Technologies, LP v. [read post]
25 Aug 2011, 9:31 am by Rantanen
By Jason Rantanen Genetics Institute, LLC v. [read post]
7 May 2012, 10:51 am by Rantanen
By Jason Rantanen Otsuka Pharmaceutical Co., Ltd. v. [read post]
1 Dec 2011, 7:40 pm by Rantanen
By Jason Rantanen Teva Pharmaceutical Industries Ltd. v. [read post]
8 Sep 2011, 12:01 pm by Rantanen
By Jason Rantanen (Note: Given the almost certain passage of H.R. 1249 by the Senate, this analysis refers to that version of the pending patent legislation. [read post]
21 Aug 2018, 12:09 pm by Jason Rantanen
By Jason Rantanen The Innovation, Business & Law Center at the University of Iowa College of Law is hosting the USPTO’s China Intellectual Property Roadshow next Tuesday from 8:45 – 4:15 p.m. [read post]
23 Nov 2010, 1:00 am by Jason Rantanen
By Jason Rantanen In an earlier post, I summarized the Federal Circuit's affirmance of a preliminary injunction prohibiting Apotex from marketing its generic version of AstraZeneca's budesonide in AstraZeneca LP v. [read post]
3 Oct 2011, 1:23 pm by Rantanen
By Jason Rantanen The Supeme Court continues to take an active interest in patent cases, with three currently pending before the Court. [read post]